64 related articles for article (PubMed ID: 27774675)
1. Case of lichen planus induced by sitagliptin phosphate hydrate.
Ohtani A; Takenaka Y; Ishiguro N; Kawashima M
J Dermatol; 2017 Sep; 44(9):1081-1082. PubMed ID: 27774675
[No Abstract] [Full Text] [Related]
2. Sitagliptin and Angioedema.
Arcani R; Martinez S; Gayet S
Ann Intern Med; 2017 Jul; 167(2):142-143. PubMed ID: 28554195
[No Abstract] [Full Text] [Related]
3. A Case of Sitagliptin-Induced Mild Acute Pancreatitis.
Kocak MZ; Aktas G; Erkus E; Duman TT; Atak BM; Sahin D; Savli H
J Coll Physicians Surg Pak; 2018 Apr; 28(4):334. PubMed ID: 29615184
[No Abstract] [Full Text] [Related]
4. Rare allergic reaction of the kidney: sitagliptin-induced acute tubulointerstitial nephritis.
Alsaad AA; Dhannoon SM; Pantin SA; Porter IE
BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27436034
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin for Type 2 diabetes: a 2015 update.
Lee M; Rhee MK
Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):597-610. PubMed ID: 26000559
[TBL] [Abstract][Full Text] [Related]
6. Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study.
Majumdar SR; Josse RG; Lin M; Eurich DT
J Clin Endocrinol Metab; 2016 May; 101(5):1963-9. PubMed ID: 26930183
[TBL] [Abstract][Full Text] [Related]
7. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
8. [Annual monitoring of side effects of administering sitagliptin in patients with type 2 diabetes mellitus].
Andel M; Skrha P; Kraml P; Potockova J; Hoffmanova I; Silhova E; Fontana J; Richterova A; Gadiredi M; Busek P; Sromova L; Šedo A
Vnitr Lek; 2016; 62(6):455-61. PubMed ID: 27485843
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
[TBL] [Abstract][Full Text] [Related]
10. Lichen planus associated with metformin therapy.
Azzam H; Bergman R; Friedman-Birnbaum R
Dermatology; 1997; 194(4):376. PubMed ID: 9252768
[No Abstract] [Full Text] [Related]
11. Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin.
Succurro E; Palleria C; Ruffo M; Serra R; Arturi F; Gallelli L
Curr Drug Saf; 2017; 12(1):10-12. PubMed ID: 27758711
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.
Tseng CH
Ann Med; 2015; 47(7):561-9. PubMed ID: 26426676
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
[TBL] [Abstract][Full Text] [Related]
14. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan.
Wang SH; Chen DY; Lin YS; Mao CT; Tsai ML; Hsieh MJ; Chou CC; Wen MS; Wang CC; Hsieh IC; Hung KC; Chen TH
PLoS One; 2015; 10(6):e0131122. PubMed ID: 26115092
[TBL] [Abstract][Full Text] [Related]
16. Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study.
Yang TY; Liaw YP; Huang JY; Chang HR; Chang KW; Ueng KC
Acta Diabetol; 2016 Jun; 53(3):461-8. PubMed ID: 26687195
[TBL] [Abstract][Full Text] [Related]
17. Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.
Peng XV; Marcinak JF; Raanan MG; Cao C
Diabetes Obes Metab; 2017 Aug; 19(8):1127-1134. PubMed ID: 28239939
[TBL] [Abstract][Full Text] [Related]
18. Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis.
Barnett AH; Arnoldini S; Hunt B; Subramanian G; Hoxer CS
Diabetes Obes Metab; 2018 Aug; 20(8):1921-1927. PubMed ID: 29652101
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α
Lovshin JA; Rajasekeran H; Lytvyn Y; Lovblom LE; Khan S; Alemu R; Locke A; Lai V; He H; Hittle L; Wang W; Drucker DJ; Cherney DZI
Diabetes Care; 2017 Aug; 40(8):1073-1081. PubMed ID: 28550195
[TBL] [Abstract][Full Text] [Related]
20. Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study.
Farngren J; Persson M; Ahrén B
Diabetes Obes Metab; 2018 Aug; 20(8):1911-1920. PubMed ID: 29645341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
